Source: Washington Citybizlist

Flaskworks: Northwest Biotherapeutics Acquires Flaskworks

Northwest Biotherapeutics (OTCQB: NWBO), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, today announced that the Company has acquired Flaskworks,

Read full article »
Flaskworks's Competitors | Flaskworks's News | Flaskworks's Financials
Stay up-to-date with the latest news on Flaskworks
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Shashi Murthy's photo - Founder of Flaskworks

Founder

Shashi Murthy

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Flaskworks